| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥353.4B | ¥154.6B | +128.6% |
| Operating Income | ¥16.4B | ¥4.9B | +235.8% |
| Ordinary Income | ¥17.1B | ¥4.6B | +270.2% |
| Net Income | ¥39.1B | ¥24.9B | +56.8% |
| ROE | 24.8% | 30.7% | - |
FY2026 Q3 consolidated results demonstrate exceptional top-line expansion driven primarily by M&A activities. Revenue reached ¥353.4B (YoY +128.6%, +¥198.8B), operating income ¥16.4B (+235.8%, +¥11.5B), ordinary income ¥17.1B (+270.2%, +¥12.5B), and net income ¥39.1B (+56.8%, +¥14.2B). The revenue surge reflects consolidation of newly acquired subsidiaries including Surtec Kariya Group, which contributed materially to the Innovative Manufacturing segment. Operating margin improved to 4.6% from 3.2% YoY, though profitability remains constrained by relatively low gross margins. A significant non-recurring gain of ¥2,846M from negative goodwill recognition boosted net income substantially. Total assets expanded to ¥595.9B from ¥322.4B, primarily due to property, plant and equipment additions and working capital increases associated with M&A transactions. The balance sheet shows elevated leverage with debt-to-equity approaching 2.78x, warranting attention to financial flexibility.
Revenue growth of 128.6% was predominantly driven by consolidation scope expansion through acquisitions. The Innovative Manufacturing segment grew from ¥14.3B to ¥33.8B (+135.9%), now representing 95.6% of total revenue and clearly establishing this as the core business. Professional Solution segment revenue increased from ¥1.0B to ¥2.0B (+98.2%), while Investment segment contributed ¥0.1B (+10.2%). Organic growth contribution appears limited given the magnitude of M&A-driven expansion. According to segment notes, Surtec Kariya Group consolidation in Q3 added ¥23.4B to Innovative Manufacturing segment assets, indicating substantial scale addition. The prior year period also reflected acquisition of Iwawi and Excel Group, contributing ¥12.8B in segment assets.
Operating profit expansion of 235.8% to ¥16.4B significantly outpaced revenue growth, driven by both scale effects and negative goodwill recognition classified as extraordinary gains. The Innovative Manufacturing segment generated operating income of ¥1.6B (margin 4.6%) compared to ¥0.5B (margin 3.3%) in the prior year. Professional Solution segment returned to profitability with ¥94M operating income versus ¥31M loss previously. Investment segment posted an operating loss of ¥9M versus ¥50M profit in the prior year. Segment profit as a percentage of consolidated operating income shows Innovative Manufacturing contributing 94.8%, Professional Solution 5.8%, with Investment segment in deficit.
The gap between ordinary income (¥17.1B) and operating income (¥16.4B) was relatively narrow at ¥0.7B, representing 2.0% of revenue. Non-operating income net contribution remained modest, suggesting limited impact from financial activities or equity method gains. The substantial variance between net income (¥39.1B) and ordinary income (¥17.1B) of ¥22.0B (difference of 128.7%) is attributed to extraordinary gains, specifically negative goodwill of ¥2,846M from Surtec Kariya acquisition as disclosed in segment notes. This non-recurring factor materially elevated reported net income beyond operational earnings power. Adjusting for this extraordinary item, normalized net income would approximate ¥36.3B, still showing strong growth but with sustainability dependent on acquired business performance.
This represents a revenue up, profit up pattern, with the critical qualifier that profit expansion incorporates significant non-recurring gains that mask underlying operational profitability challenges indicated by the 4.6% operating margin.
The Innovative Manufacturing segment dominates operations with ¥33.8B revenue (95.6% share) and ¥1.6B operating income (94.8% contribution), establishing this clearly as the core business. Segment operating margin of 4.6% reflects low profitability despite scale, indicating either competitive pricing pressures or cost structure challenges. Professional Solution segment generated ¥2.0B revenue (5.6% share) with ¥94M operating income, achieving a superior margin of 4.8% and returning to profitability after prior year losses. Investment segment remains marginal at ¥0.1B revenue (0.4% share) with ¥9M operating loss, suggesting this is an exploratory or incubation function. Material margin differences between segments are limited, with Professional Solution marginally outperforming Manufacturing despite smaller scale. The concentration of 95.6% revenue and 94.8% profit in Manufacturing creates single-segment dependency risk, though this aligns with the company's strategic focus on manufacturing expansion through M&A.
[Profitability] ROE of 24.7% substantially exceeds the company's historical levels, though this is heavily influenced by extraordinary gains and elevated financial leverage rather than operational improvements. Net profit margin of 11.1% compares to prior results but includes ¥2.8B negative goodwill gain, making adjusted margin closer to 10.3%. Operating margin of 4.6% improved from 3.2% YoY by 1.4pt but remains constrained, indicating limited pricing power or high cost structure. [Cash Quality] Cash and deposits of ¥140.6B provide coverage of 2.57x against short-term debt of ¥54.6B, indicating adequate liquidity buffer. However, accounts receivable increased ¥55.8B (+109.5%) to ¥107.0B, resulting in DSO of approximately 110 days, substantially elevated and suggesting collection cycle deterioration. [Investment Efficiency] Total asset turnover of 0.593 reflects capital-intensive operations following M&A-driven asset base expansion. Inventory turnover days of approximately 14 days improved from prior periods, though manufacturing segment characteristics require monitoring of production efficiency. [Financial Health] Equity ratio calculated as total equity ¥157.6B divided by total assets ¥595.9B yields 26.5%, below healthy levels and confirming high leverage. Current ratio of 116.8% provides minimal short-term coverage above the 100% threshold. Debt-to-equity ratio of approximately 2.78 significantly exceeds prudent levels of 1.0x, creating financial flexibility constraints and interest rate sensitivity.
Cash and deposits increased ¥75.6B YoY (+116.2%) to ¥140.6B, representing a substantial liquidity build despite high leverage. This accumulation likely reflects borrowing proceeds for M&A transactions and working capital expansion rather than organic cash generation. Operating profit growth of ¥11.5B contributed to cash generation capacity, though actual operating cash flow realization is masked by working capital movements. Accounts receivable expanded ¥55.8B and inventory increased ¥4.4B, together absorbing approximately ¥60B of cash that would otherwise flow through operations. Accounts payable increased ¥66.0B, providing partial offset through supplier credit extension, though this also signals scaled-up procurement. The ¥110-day accounts receivable cycle indicates significant cash trapped in collections, requiring focused credit management. Investment activities are inferred from property, plant and equipment increasing ¥112.6B (+99.9%), primarily reflecting acquired subsidiary assets rather than organic capital expenditure. Financing activities show short-term borrowings up ¥27.6B and long-term debt up ¥47.9B, totaling approximately ¥75.5B in debt increase to fund acquisitions and working capital. The cash position of ¥140.6B against total debt (short-term ¥54.6B plus current portion and long-term debt) suggests adequate near-term coverage, though free cash flow generation capacity from operations requires verification through full cash flow statements.
Ordinary income of ¥17.1B versus operating income of ¥16.4B shows non-operating net contribution of approximately ¥0.7B, representing 2.0% of revenue and indicating minimal reliance on financial income or equity method gains. This tight alignment between operating and ordinary income suggests core business operations drive results. The substantial gap between net income (¥39.1B) and ordinary income (¥17.1B) of ¥22.0B is attributable to extraordinary items, specifically negative goodwill of ¥2,846M from Surtec Kariya consolidation as disclosed. Adjusting for this non-recurring gain, normalized net income approximates ¥36.3B, still strong but with operating margin of 4.6% indicating modest operational profitability. Non-operating income composition is not fully detailed but the limited ¥0.7B contribution suggests interest and dividend income plus minor financial gains. The negative goodwill gain, while legitimate under acquisition accounting, represents a one-time measurement event rather than sustainable earnings, warranting distinction between reported and recurring profit. Operating cash flow data is unavailable for quarterly periods, preventing direct comparison to net income for accruals assessment. However, the ¥55.8B increase in accounts receivable against ¥39.1B net income signals potential accruals quality concern, as revenue recognition is outpacing cash collection by a material margin.
Full-year guidance calls for revenue of ¥500.0B, operating income ¥22.5B, ordinary income ¥21.8B, and net income ¥39.0B. Q3 cumulative results show revenue achievement of 70.7% (¥353.4B / ¥500.0B), operating income 72.9%, ordinary income 78.4%, and net income 100.3%. Net income has already exceeded full-year guidance by 0.3%, indicating substantial front-loading or conservative initial forecasting. For a nine-month period (Q3), standard progress would be 75%, meaning operating income at 72.9% is slightly behind pace by 2.1pt while net income materially exceeds plan. The revenue shortfall of 4.3pt versus 75% standard suggests Q4 requires ¥146.6B, representing 41.5% of cumulative nine-month revenue in a single quarter, which appears challenging without additional M&A or extraordinary seasonality. The net income guidance achievement of 100.3% suggests either guidance will be revised upward or Q4 faces headwinds. Forecast notes indicate assumed revenue growth of 99% YoY (prior year ¥251.3B implied full-year), operating income growth 106.3%, and ordinary income growth 96.6%, all reflecting M&A contributions. The company has not disclosed explicit assumption changes, but the negative goodwill gains captured in Q3 were likely not fully incorporated in original guidance, explaining net income overachievement. Close monitoring of Q4 revenue trajectory and potential guidance revision is warranted.
The company maintains a zero dividend policy with no interim or year-end dividend declared. Annual dividend per share is ¥0, unchanged from prior periods. With net income of ¥39.1B and no dividends distributed, the payout ratio is 0%, indicating complete retention of earnings for internal reinvestment and M&A funding. This zero-payout stance aligns with the company's growth-oriented capital allocation strategy prioritizing acquisition-led expansion over immediate shareholder returns. No share buyback activity is disclosed in available data. Total return ratio (dividends plus buybacks divided by net income) is therefore 0%. The absence of shareholder returns is sustainable from a cash perspective given ¥140.6B in cash reserves, but reflects management's strategic choice to preserve capital for business development rather than return cash. Given the high leverage (D/E 2.78x) and working capital demands, retaining earnings for debt reduction and operational stability would be prudent before initiating dividends. Future dividend policy initiation would require demonstrated free cash flow generation and deleveraging progress.
M&A integration execution risk represents the primary concern as the company has rapidly expanded through multiple acquisitions (Iwawi, Excel Group, Surtec Kariya) within 18 months. Integration challenges including operational alignment, system consolidation, culture integration, and realization of projected synergies could result in underperformance of acquired entities. The ¥2,846M negative goodwill suggests acquisition prices below fair value, but also indicates potential challenges in seller businesses that warranted discounted valuations. Quantified impact: failure to achieve projected synergies could result in operating margin remaining at or below current 4.6% versus industry median 8.7%, representing ¥14.5B annual operating income gap on current revenue base.
Working capital deterioration and cash conversion risk is evidenced by accounts receivable DSO extending to 110 days, substantially above the manufacturing sector median of 83 days. The ¥55.8B receivables increase outpaced revenue growth on a relative basis, suggesting either extended payment terms to support sales, customer credit quality issues, or collection process weaknesses. Quantified impact: reducing DSO from 110 to industry median 83 days would release approximately ¥26B in trapped cash (27-day improvement × ¥353.4B revenue / 365 days), material to liquidity management.
Financial leverage and interest rate sensitivity risk stems from D/E ratio of 2.78x, substantially exceeding manufacturing sector median of approximately 0.53x (implied from financial leverage of 1.53x and equity ratio 63.8%). Total borrowings increased ¥75.5B, and with interest coverage of 7.32x, a 100bp interest rate increase on ¥120B+ debt would add approximately ¥1.2B annual interest expense, reducing ordinary income by 7.0%. Combined with covenant compliance risk and refinancing risk on short-term borrowings of ¥54.6B, financial flexibility is constrained until deleveraging occurs.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: The company's operating margin of 4.6% substantially trails the manufacturing industry median of 8.7% (IQR: 5.1%-12.6%, n=100 for 2025-Q3), indicating competitive positioning challenges or cost structure inefficiencies requiring improvement. Net profit margin of 11.1% exceeds the industry median of 6.4% (IQR: 3.3%-9.3%), though this is inflated by the ¥2,846M non-recurring negative goodwill gain; adjusting to 10.3% would still show favorable positioning but narrows the advantage. ROE of 24.7% significantly exceeds the industry median of 5.2% (IQR: 3.0%-8.3%), though this is driven by elevated financial leverage rather than superior operational returns, as ROA of approximately 6.6% compares to industry median 3.3%.
Financial Health: Equity ratio of 26.5% falls far below the industry median of 63.8% (IQR: 49.4%-74.5%), placing the company in the bottom quartile for financial stability and confirming high leverage risk. Current ratio of 116.8% substantially underperforms the industry median of 2.83x (IQR: 2.11x-3.80x), indicating constrained short-term liquidity relative to peers. Financial leverage of 3.78x is more than double the industry median of 1.53x (IQR: 1.31-1.86), highlighting aggressive capital structure relative to sector norms.
Efficiency: Asset turnover of 0.593 slightly exceeds the industry median of 0.58 (IQR: 0.41-0.66), suggesting reasonable asset utilization despite rapid expansion. Receivables turnover of approximately 110 days compares unfavorably to the industry median of 83 days (IQR: 68-114), confirming collection cycle weakness. Operating working capital turnover days would benefit from reduction in receivables cycle to approach industry median of 108 days.
Growth: Revenue growth of 128.6% YoY dramatically exceeds the industry median of 2.8% (IQR: -1.7% to 8.1%), though this is M&A-driven rather than organic. EPS growth comparison is distorted by extraordinary gains. The Rule of 40 metric (growth rate plus margin) would calculate as approximately 133.2% (128.6% growth + 4.6% margin), far exceeding the industry median of 11%, though this is non-sustainable due to M&A effects.
Industry: Manufacturing sector (n=100 companies), Comparison period: 2025-Q3, Source: Proprietary analysis
M&A-driven transformation with integration execution as critical determinant: The company has executed a high-velocity acquisition strategy that more than doubled revenue within one year, fundamentally transforming scale and market positioning. The Innovative Manufacturing segment now operates at ¥33.8B quarterly revenue run-rate versus ¥14.3B prior year, establishing significantly larger operational footprint. Success hinges on effective integration of Surtec Kariya, Iwawi, and Excel Group to realize projected synergies and improve the below-industry operating margin of 4.6% toward sector median 8.7%. The ¥2,846M negative goodwill gain provides one-time profit boost but also signals acquisition complexity requiring management attention. Observable trend: segment profit contribution from Innovative Manufacturing improved from 96.1% to 94.8% of total operating income, showing improved diversification, though concentration risk remains elevated.
Balance sheet stress requiring deleveraging and working capital optimization: Financial leverage of D/E 2.78x positions the company at 2.5 times industry median, creating vulnerability to interest rate increases and limiting financial flexibility for additional growth investments. The ¥75.5B debt increase funded acquisitions but elevated interest burden to ¥2.2B annually (implied from interest coverage 7.32x). Simultaneously, working capital absorbed significant cash with receivables DSO extending to 110 days versus industry median 83 days, representing approximately ¥26B in excess tied-up capital. Cash position of ¥140.6B provides near-term cushion but optimal capital allocation would prioritize debt reduction and receivables management. Observable trend: current ratio of 116.8% versus industry median 283% indicates constrained liquidity buffer that warrants improvement to create operational resilience.
Earnings quality and sustainability requiring normalization for investment assessment: Reported net income of ¥39.1B includes ¥2,846M non-recurring negative goodwill gain (7.3% of net income), requiring adjustment to ¥36.3B for normalized run-rate assessment. This still represents strong 45.7% YoY growth, but the operating margin of 4.6% trailing industry median by 4.1pt indicates profitability improvement potential of ¥14.5B annually at current revenue levels. The company has already achieved 100.3% of full-year net income guidance in nine months, suggesting either conservative forecasting or Q4 headwinds, with revenue requiring ¥146.6B in Q4 (41.5% of YTD) to meet ¥500B guidance. Zero dividend policy with 0% payout ratio reflects growth reinvestment priority but also recognizes leverage constraints. Observable trend: full-year guidance achievement by Q3 for net income while operating metrics lag standard 75% progress indicates earnings concentration and potential quarterly volatility warranting monitoring.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.